在为胃肠道癌症接受化疗的患者中,症状体验和影响因素:一种定性研究
Xiaoying Huang1, Heng Yang1, Yanyan Qiao2
1Department of Oncology, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Frontiers in psychology
|June 11, 2024
概括
在中国,为胃肠癌接受化疗的患者报告症状不佳. 多种因素影响这些症状,突出需要改善护理护理和支持.
科学领域:
- 在瘤学瘤学.
- 胃肠病学 胃肠病学
- 患者体验研究 研究研究
背景情况:
- 化疗 (CTX) 是胃肠癌的关键治疗方法.
- 了解CTX期间患者的症状经历对于有效的护理至关重要.
研究的目的:
- 探索在中国接受CTX的胃肠道癌症患者的症状经历.
- 确定影响这些症状体验的因素.
主要方法:
- 与13名接受CTX的胃肠道癌症患者进行了半结构面试.
- 数据分析遵循了Colaizzi的7步方法,涉及详细的编码和主题验证.
主要成果:
- 九个主题出现,分为症状体验特征和影响因素.
- 患者在CTX期间报告了整体症状体验不佳.
结论:
- 在CTX上治疗肠道癌症患者的症状体验低于最佳,并受到各种因素的影响.
- 加强护理评估,医生与患者的沟通,社会支持和智能管理对于改善患者的治疗结果至关重要.
相关概念视频
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
194
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
194
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
159
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
159
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
224
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
224
Factors Influencing Drug Absorption: Disease States and Pharmacology
495
Multiple disease states can significantly influence the oral drug absorption process by affecting blood flow and the functionality of the gastrointestinal (GI) system. Various GI diseases, including conditions that alter GI motility, such as diarrhea, decreased acid secretions (achlorhydria), and infections, have been associated with reduced drug absorption.
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
495
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
261
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
261
Assessment of the Gastrointestinal System I: Subjective Data
177
Assessing the gastrointestinal (GI) system is a complex process that begins with collecting subjective data. This data, collected through patient interviews, provides crucial insights into the patient's health history, perception patterns, and lifestyle habits, all contributing significantly to GI health.
Health History
The initial step in assessing the GI system is obtaining a comprehensive health history. This includes inquiring about the patient's history or presence of problems...
Health History
The initial step in assessing the GI system is obtaining a comprehensive health history. This includes inquiring about the patient's history or presence of problems...
177


